Balyasny Asset Management L.P. Sells 205,778 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Balyasny Asset Management L.P. lessened its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,222 shares of the company's stock after selling 205,778 shares during the period. Balyasny Asset Management L.P. owned 0.19% of Guardian Pharmacy Services worth $2,415,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Franklin Resources Inc. acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $8,575,000. Geode Capital Management LLC acquired a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $4,073,000. Renaissance Technologies LLC acquired a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $2,859,000. Royce & Associates LP grew its stake in Guardian Pharmacy Services by 185.3% during the fourth quarter. Royce & Associates LP now owns 214,000 shares of the company's stock worth $4,336,000 after purchasing an additional 139,000 shares during the period. Finally, Northern Trust Corp acquired a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $1,479,000.

Analyst Ratings Changes

Separately, Truist Financial raised their target price on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, April 11th.

Guardian Pharmacy Services Trading Down 1.2%

NYSE GRDN traded down $0.30 during trading hours on Friday, hitting $24.62. 88,787 shares of the company's stock were exchanged, compared to its average volume of 146,109. The stock has a 50-day simple moving average of $22.74 and a 200 day simple moving average of $21.84. Guardian Pharmacy Services, Inc. has a 1-year low of $14.16 and a 1-year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.